Organon & Co
OGN
Company Profile
Business description
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women’s health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
Contact
30 Hudson Street
Floor 33
Jersey City NJ 07302
USAT: +1 551 430-6900
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
10,000
Stocks News & Analysis
stocks
What next for these 3 high flying ASX shares?
Wesfarmers, NextDC and WiseTech shares have been flying this year. How do our analysts rate their prospects and valuation?
stocks
11 ASX stocks offering great value right now
These high-quality companies are our top picks for investors wanting to boost their domestic exposure.
stocks
ASX stock gets a moat upgrade
Morningstar analyst Mark Taylor upgrades Seven Group Holdings' moat and fair value rating.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,150.10 | 129.20 | 1.61% |
| CAC 40 | 8,198.84 | 41.15 | -0.50% |
| DAX 40 | 18,823.02 | 46.34 | -0.25% |
| Dow JONES (US) | 39,908.00 | 349.89 | 0.88% |
| FTSE 100 | 8,411.17 | 34.63 | -0.41% |
| HKSE | 19,376.53 | 302.82 | 1.59% |
| NASDAQ | 16,742.39 | 231.21 | 1.40% |
| Nikkei 225 | 38,920.26 | 534.53 | 1.39% |
| NZX 50 Index | 11,728.06 | 202.18 | 1.75% |
| S&P 500 | 5,308.15 | 61.47 | 1.17% |
| S&P/ASX 200 | 7,881.30 | 127.60 | 1.65% |
| SSE Composite Index | 3,122.40 | 2.50 | 0.08% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.13% |
| Telstra Group Ltd TLS | 3.69 | 0.02 | 0.55% |
| South32 Ltd S32 | 3.75 | 0.08 | 2.18% |
| PYC Therapeutics Ltd PYC | 0.10 | 0.01 | -7.62% |
| Pilbara Minerals Ltd PLS | 4.01 | 0.03 | 0.75% |
| Incitec Pivot Ltd IPL | 2.97 | 0.15 | 5.32% |
| Red 5 Ltd RED | 0.49 | 0.02 | 4.26% |
| Pantoro Ltd PNR | 0.09 | 0.01 | 7.41% |
| Vicinity Centres VCX | 1.98 | 0.05 | 2.60% |
| Mirvac Group MGR | 2.15 | 0.06 | 2.87% |